Rothschild Investment LLC Guardant Health, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of GH stock, worth $3,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 55
100.0%
Holding current value
$3,229
Previous $1.59 Million
58.88%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
329Shares Held
114MCall Options Held
680KPut Options Held
1.67M-
Vanguard Group Inc Valley Forge, PA11.6MShares$342 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$330 Million0.01% of portfolio
-
Baillie Gifford & CO5.87MShares$172 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$132 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$131 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...